| Financial Year |
March 31 2023 |
| Monetary Funds |
730,315,421.54 |
| Held-for-trading Financial Assets |
221,446,027.31 |
| Notes Receivable |
10,588,381.74 |
| Accounts Receivable |
988,279,313.26 |
| Advances to Suppliers |
58,049,606.11 |
| Other Receivables |
33,782,093.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
949,384,890.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
800,049,664.02 |
| Total Current Assets |
3,980,315,329.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
10,528,098.31 |
| Investment Properties |
12,052,713.88 |
| Fixed Assetes |
769,199,087.00 |
| Under-construction Projects |
68,783,704.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
129,628,018.03 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
175,232.06 |
| Deferred Income Tax Assets |
10,335,260.92 |
| Other Non-Current Assets |
34,622,830.19 |
| Sub-Total of Non-Current Assets |
1,040,149,861.01 |
| Total Assets |
5,020,465,190.90 |
| Short-Term Loans |
1,299,224,566.53 |
| Trading Financial liabilities |
594,673.23 |
| Notes Payable |
37,679,092.49 |
| Accounts Payable |
542,546,299.13 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
85,452,977.78 |
| Taxes Payable |
36,411,756.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
58,275,690.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,220,217.64 |
| Other Current Liabilities |
5,401,349.98 |
| Sub-Total of Current Liabilities |
2,111,045,633.54 |
| Long-term Loans |
94,933,500.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,550,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,777,710.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
143,742,794.36 |
| Total Liabilities |
2,254,788,427.90 |
| Paid-In Capital(Or Share Stock) |
1,133,684,103.00 |
| Capital Surplus |
1,060,664,925.34 |
| Surplus Reserve |
47,940,325.35 |
| LESS:Treasury Stock |
100,078,331.51 |
| Undistributed Profits |
598,725,545.13 |
| Minority Stockholder's Interest |
24,740,195.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,740,936,567.31 |
| Owner's Equity（Stockholder's Equity） |
2,765,676,763.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,020,465,190.90 |
